Sign Up to like & get
recommendations!
1
Published in 2021 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.912
Abstract: Multiple‐dose pharmacokinetics (PK) and safety were investigated in this phase 1 study of PF‐06372865, a positive allosteric modulator of α2/3/5 subunit‐containing γ‐aminobutyric acid A receptors (NCT03351751). In 2 cohorts (7‐8 PF‐06372865 and 2 placebo in…
read more here.
Keywords:
allosteric modulator;
oral doses;
safety;
twice daily ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-020-04067-3
Abstract: Purpose Fedratinib is an orally administered Janus kinase 2-selective inhibitor that is indicated for the treatment of adult patients with intermediate-2 or high-risk myelofibrosis in the United States. Fedratinib is metabolized by multiple cytochrome P450s…
read more here.
Keywords:
fedratinib;
oral doses;
oral dose;
dose fedratinib ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Chemical research in toxicology"
DOI: 10.1021/acs.chemrestox.1c00307
Abstract: Assessment of structure-activity relationships (SARs) for predicting severe drug-induced liver injury (DILI) is essential since in vivo and in vitro preclinical methods cannot detect many druglike compounds disrupting liver functions. To date, plenty of SAR…
read more here.
Keywords:
drug induced;
oral doses;
dili;
severe drug ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Clinical and Translational Science"
DOI: 10.1111/cts.13425
Abstract: Global interest in the non‐intoxicating cannabis constituent, cannabidiol (CBD), is increasing with claims of therapeutic effects across a diversity of health conditions. At present, there is sufficient clinical trial evidence to support the use of…
read more here.
Keywords:
oral doses;
safety;
efficacy;
evidence ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of Veterinary Pharmacology and Therapeutics"
DOI: 10.1111/jvp.13061
Abstract: Abstract The study was designed to determine the pharmacokinetic profile and bioavailability of a novel pregabalin 50 mg/ml oral solution formulation (Bonqat®, Orion Corporation Orion Pharma) in 6 healthy laboratory cats. The cats received pregabalin as…
read more here.
Keywords:
oral doses;
solution formulation;
solution;
pregabalin oral ... See more keywords